2023 - Research.com Medicine in Canada Leader Award
2009 - Fellow of the Royal Society of Canada Academy of Science
His primary areas of investigation include Acquired immunodeficiency syndrome, Immunology, Internal medicine, Viral load and Substance abuse. His Acquired immunodeficiency syndrome research incorporates elements of Viral disease, Mortality rate, Psychiatry, Pharmacotherapy and Intensive care medicine. The Immunology study combines topics in areas such as Epidemiology, Incidence and Antiretroviral therapy.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Sida and Surgery. His biological study spans a wide range of topics, including Proportional hazards model and Drug resistance. His study in Substance abuse is interdisciplinary in nature, drawing from both Gerontology, Cohort study, Family medicine, SAFER and Drug.
Julio S. G. Montaner focuses on Acquired immunodeficiency syndrome, Internal medicine, Immunology, Cohort and Demography. His research integrates issues of Epidemiology, Gerontology and Public health in his study of Acquired immunodeficiency syndrome. His Internal medicine study often links to related topics such as Viral load.
His Immunology research is multidisciplinary, relying on both Chemotherapy, Oncology and Drug resistance. The study incorporates disciplines such as Odds ratio, Cohort study, Psychiatry, Multivariate analysis and Prospective cohort study in addition to Cohort. His Demography research is multidisciplinary, incorporating perspectives in Men who have sex with men and Incidence.
Julio S. G. Montaner mainly investigates Acquired immunodeficiency syndrome, Demography, Cohort, Viral load and Internal medicine. His Acquired immunodeficiency syndrome research is multidisciplinary, incorporating elements of Psychological intervention, Epidemiology, Gerontology, Environmental health and Public health. His work in Demography addresses issues such as Confidence interval, which are connected to fields such as Odds ratio and Antiretroviral therapy.
His biological study deals with issues like Psychiatry, which deal with fields such as HIV-positive people. His Viral load study necessitates a more in-depth grasp of Immunology. His research in Internal medicine focuses on subjects like Ritonavir, which are connected to Atazanavir.
Demography, Acquired immunodeficiency syndrome, Cohort, Confidence interval and Gerontology are his primary areas of study. Julio S. G. Montaner interconnects Odds ratio, Logistic regression, Treatment as prevention, Injection drug use and Prospective cohort study in the investigation of issues within Demography. His work deals with themes such as Mortality rate, Internal medicine, Incidence and Harm reduction, Public health, which intersect with Acquired immunodeficiency syndrome.
His Internal medicine study combines topics from a wide range of disciplines, such as Immunology and Drug resistance. His Cohort research incorporates themes from Psychiatry, Cohort study, Viral load and Heroin. Julio S. G. Montaner focuses mostly in the field of Confidence interval, narrowing it down to topics relating to Proportional hazards model and, in certain cases, Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Richard K. Sterling;Eduardo Lissen;Eduardo Lissen;Nathan Clumeck;Ricard Sola.
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
Francesca J. Torriani;Maribel Rodriguez-Torres;Jürgen K. Rockstroh;Eduardo Lissen.
The New England Journal of Medicine (2004)
Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society–USA Panel
Charles C. J. Carpenter;David A. Cooper;Margaret A. Fischl;Jose M. Gatell.
Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.
Jacob P. Lalezari;Keith Henry;Mary O'Hearn;Julio S.G. Montaner.
The New England Journal of Medicine (2003)
Treatment for adult HIV infection : 2006 recommendations of the international AIDS society-USA panel
Scott M. Hammer;Michael S. Saag;Mauro Schechter;Julio S. G. Montaner.
Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral Therapy
Robert S. Hogg;Katherine V. Heath;Benita Yip;Kevin J. P. Craib.
A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.
Julio S. G. Montaner;Peter Reiss;David Cooper;Stefano Vella.
Antiretroviral Therapy for HIV Infection in 1997: Updated Recommendations of the International AIDS Society—USA Panel
Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch.
Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel
Patrick G. Yeni;Scott M. Hammer;Charles C. J. Carpenter;David A. Cooper.
Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug Therapy
Robert S. Hogg;Benita Yip;Keith J. Chan;Evan Wood.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: